Heron Therapeutics, Inc. /De/

Ownership Transactions Reported by 19 Insiders

Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4242 Campus Point Court, Suite 200, San Diego, CA

Insiders trading volume in the past year

Heron Therapeutics, Inc. /De/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rubric Capital Management LP 10%+ Owner $43.7M +$3.58M +8.94% Aug 8, 2025
Adam Morgan Director $13.3M +$2.65M +24.8% Aug 8, 2025
Velan Capital Investment Management LP Other* $9.68M Jan 30, 2023
Mark E. Hensley Chief Operating Officer $3.08M May 6, 2025
Barry D. Quart Chief Executive Officer, Director $2.14M Jan 18, 2023
Craig Collard Chief Executive Officer, Director $1.33M Jul 31, 2025
Kevin Kotler Director $1.24M Feb 22, 2023
Ira Duarte EVP, Chief Financial Officer $840K Jul 19, 2025
William P. Forbes EVP, Chief Development Officer $812K Jul 31, 2025
John Poyhonen President & CCO $456K Apr 13, 2023
David Leslie Szekeres EVP, Chief Operating Officer $418K Jul 13, 2023
Kimberly Manhard EVP, Drug Development $416K Apr 13, 2023
Sharmila Dissanaike Director $292K Jan 31, 2025
Susan Rodriguez Director $292K Jan 31, 2025
Waage Christian Director $284K Jan 31, 2025
Craig Johnson Director $283K Jan 31, 2025
Stephen Davis Director $249K Dec 16, 2022
Michael Kaseta Director $209K Jan 31, 2025
Lisa Peraza VP, Chief Accounting Officer $208K Jan 19, 2024

Recent Insider Transactions by Companies or Individuals for Heron Therapeutics, Inc. /De/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.